Terbutaline Sulfate
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Terbutaline Sulfate contains NLT 98.0% and NMT 102.0% (USP 1-Dec-2023) of terbutaline sulfate [(C12H19NO3)2 · H2SO4], calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. SPECTROSCOPIC IDENTIFICATION TESTS 〈197〉 , Infrared Spectroscopy: 197K or 197A (USP 1-Dec-2023)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. Add the following:
C. IDENTIFICATION TESTS—GENERAL 〈191〉 , Chemical Identification Tests, Sulfate: Meets the requirements (USP 1-Dec-2023)
3 ASSAY
Change to read:
PROCEDURE
Buffer: 3.15 g/L of ammonium formate and 5.49 g/L of sodium 1-hexanesulfonate in water prepared as follows. Transfer 3.15 g of ammonium formate to a 1000-mL volumetric flask, dissolve in 900 mL of water, adjust the solution with formic acid to a pH of 3.0, add 5.49 g of sodium 1-hexanesulfonate, and dilute with water to volume.
Mobile phase: Methanol and Buffer (23:77)
System suitability solution: 1.0 mg/mL of USP Terbutaline Sulfate RS and 0.4 mg/mL of USP Terbutaline Related Compound A RS in Mobile phase
Standard solution: 1.0 mg/mL of USP Terbutaline Sulfate RS in Mobile phase Sample solution: 1.0 mg/mL of Terbutaline Sulfate in Mobile phase Chromatographic system
(See Chromatography 〈621〉, System Suitability.) Mode: LC
Detector: UV 276 nm
Column: 4.6-mm × 15-cm; 5-µm packing L1 Flow rate: 1 mL/min
Injection volume: 20 µL
Run time: NLT 1.6 times the retention time of terbutaline (USP 1-Dec-2023)
System suitability
Sample: System suitability solution
[NOTE—The relative retention times for terbutaline related compound A and terbutaline are 0.9 and 1.0, respectively.] Suitability requirements
Resolution: NLT 2.0 between terbutaline related compound A and terbutaline
(USP 1-Dec-2023)
Tailing factor: NMT 2.0 for terbutaline
Relative standard deviation: NMT 0.73% (USP 1-Dec-2023) for terbutaline Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of terbutaline sulfate [(C12H19NO3)2 · H2SO4] in the portion of Terbutaline Sulfate taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of terbutaline from the Sample solution
rS = peak response of terbutaline from the Standard solution
CS = concentration of USP Terbutaline Sulfate RS in the Standard solution (mg/mL)
CU = concentration of Terbutaline Sulfate in the Sample solution (mg/mL)
Acceptance criteria: 98.0%–102.0% (USP 1-Dec-2023) on the dried basis
4 IMPURITIES
RESIDUE ON IGNITION 〈281〉: NMT 0.2%
Change to read:
ORGANIC IMPURITIES
Buffer and System suitability solution: Prepare as directed in the Assay.
Solution A: Methanol and Buffer (23:77)
Solution B: Methanol
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 100 | 0 |
| 15 | 100 | 0 |
| 35 | 80 | 20 |
| 40 | 80 | 20 |
| 42 | 100 | 0 |
| 45 | 100 | 0 |
Sensitivity solution: 0.75 µg/mL of USP Terbutaline Sulfate RS in Solution A
Standard solution: 0.003 mg/mL each of USP Terbutaline Sulfate RS, USP Terbutaline Related Compound A RS, and USP Terbutaline Related Compound D RS in Solution A
Sample solution: 1.5 mg/mL of Terbutaline Sulfate in Solution A
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 276 nm
Column: 4.6-mm × 15-cm; 5-µm packing L1
Flow rate: 1 mL/min
Injection volume: 20 µL
System suitability
Samples: System suitability solution, Sensitivity solution, and Standard solution [NOTE—See Table 2 for the relative retention times.]
Suitability requirements
Resolution: NLT 2.0 between terbutaline related compound A and terbutaline, System suitability solution Tailing factor: NMT 2.0 for terbutaline, System suitability solution
Relative standard deviation: NMT 5.0% for terbutaline, terbutaline related compound A, and terbutaline related compound D, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of terbutaline related compound A in the portion of Terbutaline Sulfate taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of terbutaline related compound A from the Sample solution
rS = peak response of terbutaline related compound A from the Standard solution
CS = concentration of USP Terbutaline Related Compound A RS in the Standard solution (mg/mL)
CU = concentration of Terbutaline Sulfate in the Sample solution (mg/mL)
Calculate the percentage of terbutaline related compound D in the portion of Terbutaline Sulfate taken:
Result = (rU/rS) × (CS/CU) × (Mr1/Mr2) × 100
rU = peak response of terbutaline related compound D from the Sample solution
rS = peak response of terbutaline related compound D from the Standard solution
CS = concentration of USP Terbutaline Related Compound D RS in the Standard solution (mg/mL)
CU = concentration of Terbutaline Sulfate in the Sample solution (mg/mL)
Mr1 = molecular weight of terbutaline related compound D sulfate salt (2:1), 724.87
Mr2 = molecular weight of terbutaline related compound D free base times 2, 626.80
Calculate the percentage of any unspecified impurity in the portion of Terbutaline Sulfate taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of any unspecified impurity from the Sample solution
rS = peak response of terbutaline from the Standard solution
CS = concentration of USP Terbutaline Sulfate RS in the Standard solution (mg/mL)
CU = concentration of Terbutaline Sulfate in the Sample solution (mg/mL)
Acceptance criteria: See Table 2. The reporting threshold is 0.05%.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Terbutaline related compound A | 0.86 | 0.2 |
| Terbutaline | 1.0 | — |
| Terbutaline related compound D | 3.4 | 0.2 |
| Any unspecified impurity | — | 0.10 |
| Total impuritiesa | — | 0.4 |
a Excluding terbutaline related compound A.
(USP 1-Dec-2023)
5 SPECIFIC TESTS
Change to read:
5.1 ACIDITY
Sample solution: 20 mg/mL in carbon dioxide-free water
Analysis: Titrate 10 mL of the Sample solution with 0.02 N sodium hy droxide VS (USP 1-Dec-2023) from a microburet to a pH of 6, determining the endpoint potentiometrically, using a calomel-glass electrode system.
Acceptance criteria: NMT 0.50 mL of 0.02 N sodium hydroxide VS (USP 1-Dec-2023) is required (0.3% as acetic acid).
5.2 LOSS ON DRYING 〈731〉
Analysis: Dry at 105° for 3 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in well-closed, light-resistant containers. Store at controlled room temperature.
Change to read:
USP REFERENCE STANDARDS 〈11〉
USP Terbutaline Sulfate RS
USP Terbutaline Related Compound A RS
2-(tert-Butylamino)-1-(3,5-dihydroxyphenyl)ethan-1-one sulfate. (C12H19NO3)2 · H2SO4 544.62
USP Terbutaline Related Compound D RS
2-[Benzyl(tert-butyl)amino]-1-(3,5-dihydroxyphenyl)ethan-1-one. C19H23NO3 313.40 (USP 1-Dec-2023)

